Clinical trial
Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II
NCT03797937 is registered in ClinicalTrials.gov with National MS Center Melsbroek as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II
- Lead sponsor
- National MS Center Melsbroek
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2018
- Completion date
- May 1, 2022
- Enrollment
- 250 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.